The report showed an approximately 25 percent reduction in 10 of the 12 symptoms studied, including the common complaints of lingering fatigue and brain fog.
Paxlovid may reduce long covid risk for some patients, VA study finds
The report showed an approximately 25 percent reduction in 10 of the 12 symptoms studied, including the common complaints of lingering fatigue and brain fog.